




Searching News Database: Levacor
HSMN NewsFeed - 9 Feb 2011
WorldHeart Pauses Enrollment in the Levacor(R) VAD Bridge-To-Transplant Study
WorldHeart Pauses Enrollment in the Levacor(R) VAD Bridge-To-Transplant Study
HSMN NewsFeed - 12 Aug 2010
WorldHeart Appoints Dr. Monica Hope as Vice President of Clinical Affairs
WorldHeart Appoints Dr. Monica Hope as Vice President of Clinical Affairs
HSMN NewsFeed - 27 Jul 2010
WorldHeart Receives FDA Approval to Add Clinical Sites in Levacor(TM) VAD Bridge-to-Transplant Study
WorldHeart Receives FDA Approval to Add Clinical Sites in Levacor(TM) VAD Bridge-to-Transplant Study
HSMN NewsFeed - 19 Jan 2010
WorldHeart Announces First U.S. Implant of Levacor(TM) VAD Implant at INTEGRIS in Oklahoma City
WorldHeart Announces First U.S. Implant of Levacor(TM) VAD Implant at INTEGRIS in Oklahoma City
HSMN NewsFeed - 8 Jan 2010
WorldHeart Receives Unconditional BTT Study Approval From FDA for Levacor(TM) VAD
WorldHeart Receives Unconditional BTT Study Approval From FDA for Levacor(TM) VAD
HSMN NewsFeed - 15 Oct 2009
WorldHeart Receives IRB Approval at First Center in the Levacor(TM) VAD BTT Clinical Trial
WorldHeart Receives IRB Approval at First Center in the Levacor(TM) VAD BTT Clinical Trial
HSMN NewsFeed - 8 Jan 2009
WorldHeart Submits IDE Application for a Pivotal Bridge-to-Transplant Study of the Levacor(TM) VAD
WorldHeart Submits IDE Application for a Pivotal Bridge-to-Transplant Study of the Levacor(TM) VAD
HSMN NewsFeed - 4 Jun 2007
WorldHeart Celebrates 1 Year of Sustained Recovery of First Levacor(TM) VAD Patient
WorldHeart Celebrates 1 Year of Sustained Recovery of First Levacor(TM) VAD Patient
HSMN NewsFeed - 14 Nov 2006
WorldHeart Announces $14.1 Million Private Placement and Plan to Restructure Its Business
WorldHeart Announces $14.1 Million Private Placement and Plan to Restructure Its Business